Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary.
Mascolo A, Di Napoli R, Balzano N, Cappetta D, Urbanek K, De Angelis A, Scisciola L, Di Meo I, Sullo MG, Rafaniello C, Sportiello L.
Mascolo A, et al. Among authors: balzano n.
Front Cardiovasc Med. 2022 Sep 21;9:1010693. doi: 10.3389/fcvm.2022.1010693. eCollection 2022.
Front Cardiovasc Med. 2022.
PMID: 36211584
Free PMC article.
Review.